- Citations, last 5 years
- 83
- Works, last 5 years
- 16
- h-index
- 28
- Scientists listed
- 3
- Grants since 2016
- 9
Grants received
2023–2028 · grant · DMRDP
GMP Manufacturing and Initial Clinical Evaluation of a Tetravalent Live Attenuated Dengue Vaccine
Keri Wyllie · Codagenix (United States) · funded by Congressionally Directed Medical Research Programs
2022–2026 · grant · JWMRP
Preclinical Development of a Balanced, Tetravalent, Live-Attenuated Vaccine Against the Four Dengue Virus Serotypes
Keri Wyllie · Codagenix (United States) · funded by Congressionally Directed Medical Research Programs
2021–2023 · research · R44
Final Preclinical Testing and Formulation of a Scalable, Live-attenuated SARS-CoV-2 Vaccine
Steffen Mueller · Codagenix (United States) · funded by National Institutes of Health
2020–2021 · research · R44
Rapid generation and testing of live-attenuated vaccines against SARS-CoV-2
Steffen Mueller · Codagenix (United States) · funded by National Institutes of Health
2017–2019 · research · R44
Pre-clinical Commercialization of a Synthetically Designed, Live-attenuated RSV Vaccine
Steffen Mueller · Codagenix (United States) · funded by National Institutes of Health
2017–2023 · research · R44
A rationally-designed, live-attenuated RSV vaccine for the elderly
Steffen Mueller · Codagenix (United States) · funded by National Institutes of Health
2017–2025 · research · R44
A rationally-designed, live-attenuated RSV vaccine for the elderly
Steffen Mueller · Codagenix (United States) · funded by National Institutes of Health
2017–2023 · research · R44
A rationally-designed, live-attenuated RSV vaccine for the elderly
Steffen Mueller · Codagenix (United States) · funded by National Institutes of Health
2017–2020 · research · R44
Pre-clinical Commercialization of a Synthetically Designed, Live-attenuated RSV Vaccine
Steffen Mueller · Codagenix (United States) · funded by National Institutes of Health